https://de.marketscreener.com/kurs/aktie/PROTAGENIC-THERAPEUTICS-I-120790234/news/Protagenic-Therapeutics-schlie-t-dritte-Kohorte-im-Einzeldosis-Teil-der-Phase-1-Studie-fur-stressb-46300971/?utm_source=telegram&utm_medium=social&utm_campaign=share